# Bexarotene

NDC: 0378-6955
Generic name: Bexarotene
Labeler / Manufacturer: Mylan Pharmaceuticals Inc.
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: Abbreviated NDA (generic)
Dosage form: CAPSULE, LIQUID FILLED
Routes: ORAL
Marketing started: 20150709

FDA application: ANDA203174

## Active ingredients

- BEXAROTENE: 75 mg/1

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0378-6955"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0378-6955
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=2d1eb4bd-51f9-4c9b-9fb1-0be5e30a3dc5